Alcon Labs Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALCON LABS INC, and when can generic versions of ALCON LABS INC drugs launch?
ALCON LABS INC has seventeen approved drugs.
There are thirty-nine US patents protecting ALCON LABS INC drugs.
There are two hundred and seventeen patent family members on ALCON LABS INC drugs in thirty-one countries and twenty-seven supplementary protection certificates in ten countries.
Summary for Alcon Labs Inc
International Patents: | 217 |
US Patents: | 39 |
Tradenames: | 14 |
Ingredients: | 12 |
NDAs: | 17 |
Drugs and US Patents for Alcon Labs Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alcon Labs Inc | CYCLOGYL | cyclopentolate hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 084108-001 | Approved Prior to Jan 1, 1982 | AT | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
Alcon Labs Inc | RHOPRESSA | netarsudil mesylate | SOLUTION/DROPS;OPHTHALMIC | 208254-001 | Dec 18, 2017 | RX | Yes | Yes | 11,021,456 | ⤷ Sign Up | ⤷ Sign Up | ||||
Alcon Labs Inc | INVELTYS | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 210565-001 | Aug 22, 2018 | RX | Yes | Yes | 10,864,219 | ⤷ Sign Up | ⤷ Sign Up | ||||
Alcon Labs Inc | INVELTYS | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 210565-001 | Aug 22, 2018 | RX | Yes | Yes | 11,219,597 | ⤷ Sign Up | ⤷ Sign Up | ||||
Alcon Labs Inc | ROCKLATAN | latanoprost; netarsudil dimesylate | SOLUTION/DROPS;OPHTHALMIC | 208259-001 | Mar 12, 2019 | RX | Yes | Yes | 10,654,844 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
Alcon Labs Inc | PATADAY ONCE DAILY RELIEF | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 206276-001 | Jan 30, 2015 | OTC | Yes | Yes | 8,791,154 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Alcon Labs Inc | LEVOBUNOLOL HYDROCHLORIDE | levobunolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 074851-001 | Oct 28, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Alcon Labs Inc
International Patents for Alcon Labs Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Hong Kong | 1208382 | ⤷ Sign Up |
Australia | 2020203213 | ⤷ Sign Up |
Mexico | 2013010039 | ⤷ Sign Up |
Hong Kong | 1194971 | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2013166385 | ⤷ Sign Up |
Spain | 2461617 | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2010127330 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Alcon Labs Inc Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1631293 | 2014/041 | Ireland | ⤷ Sign Up | PRODUCT NAME: BRIMONIDINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTRATION NO/DATE: EU/1/13/904 20140221 |
3043773 | 21C1057 | France | ⤷ Sign Up | PRODUCT NAME: MOMETASONE OU L'UN DE SES SELS AVEC OLOPATADINE OU L'UN DE SES SELS; NAT. REGISTRATION NO/DATE: NL52121 20211026; FIRST REGISTRATION: AT - 140638 20210426 |
3053913 | 2020C/510 | Belgium | ⤷ Sign Up | PRODUCT NAME: RHOKIINSA - NETARSUDIL; AUTHORISATION NUMBER AND DATE: EU/1/19/1400 20191121 |
1631293 | 2014C/042 | Belgium | ⤷ Sign Up | PRODUCT NAME: MIRVASO (BRIMONIDINE) EN FARMACEUTISCHE ZOUTEN DAARVAN VOOR GEBRUIK ALS MEDICIJN VOOR HET BEHANDELEN VAN ROSACEA GEINDUCEERDE ROODHEID; AUTHORISATION NUMBER AND DATE: EU/1/13/904 20140221 |
3053913 | 122020000016 | Germany | ⤷ Sign Up | PRODUCT NAME: NETARSUDIL, ODER EIN ENANTIOMER, DIASTEREOMER, SALZ ODER SOLVAT DAVON; REGISTRATION NO/DATE: EU/1/19/1400 20191119 |
3461484 | 122021000036 | Germany | ⤷ Sign Up | PRODUCT NAME: LATANOPROST, ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON, UND NETARSUDIL MESYLAT; REGISTRATION NO/DATE: EU/1/20/1502 20210107 |
3461484 | C202130024 | Spain | ⤷ Sign Up | PRODUCT NAME: NETARSUDIL O UN ENANTIOMERO, DIASTEREIOISOMERO, SAL O SALVADO DEL MISMO EN COMBINACION CON LATANOPROST O UNA SAL DEL MISMO; NATIONAL AUTHORISATION NUMBER: EU/1/20/1502; DATE OF AUTHORISATION: 20210107; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/20/1502; DATE OF FIRST AUTHORISATION IN EEA: 20210107 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.